Sino Biopharmaceutical ( ($HK:1177) ) has shared an update. Sino Biopharmaceutical Limited announced that its innovative drug, LM-350 ‘CDH17 ADC’, ...

MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

A doctor who believes in miracles is one who doesn’t shut the door on the seemingly impossible too soon,” writes Marc Siegel, ...

One major biotech investor just walked away from Viking Therapeutics. Here’s what the move may—and may not—mean for the ...

An announcement from NervGen Pharma ( ($TSE:NGEN) ) is now available. NervGen Pharma has announced a US$10 million non-brokered private placement ...

Compass Therapeutics Inc. (NASDAQ:CMPX) is a must-buy penny stock to buy now. On November 10, Pipe Sandler analyst Biren Amin ...

AbCellera Biologics Inc. (NASDAQ:ABCL) is a must-buy penny stock to buy now. On November 13, at the Stifel 2025 Healthcare ...

Bristol-Myers Squibb stands out in Big Pharma with strong sales growth and a solid dividend yield. Click here to read an ...

Olema Pharmaceuticals stock surged 197% after Roche reported positive trial results for a similar breast cancer drug.

While clinical ASX healthcare stocks often come with regulatory and clinical hurdles, Morgans believes this one is set to ...